Abstract Details
|
PRESENTER |
No disclosure on file |
| Carine W. Maurer, MD, PhD, FAAN (Stony Brook University School of Medicine) | Dr. Maurer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amneal Pharmaceuticals. The institution of Dr. Maurer has received research support from Alzheimer's Association & the Foundation of the American Society of Neuroradiology. The institution of Dr. Maurer has received research support from UCB Biopharma SRL. The institution of Dr. Maurer has received research support from Emalex Biosciences. The institution of Dr. Maurer has received research support from Noema Pharma. Dr. Maurer has received publishing royalties from a publication relating to health care. |
| Kathrin LaFaver, MD, FAAN | Dr. LaFaver has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. LaFaver has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acorda. Dr. LaFaver has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for WALL, WALL & FRAUENHOFER, LLP. The institution of Dr. LaFaver has received research support from Ayers Foundation. Dr. LaFaver has received publishing royalties from a publication relating to health care. Dr. LaFaver has a non-compensated relationship as a Board Member with FND Society that is relevant to AAN interests or activities. Dr. LaFaver has a non-compensated relationship as a Medical Advisor with FND Hope that is relevant to AAN interests or activities. |
| No disclosure on file | |
| Mark Hallett, MD, FAAN (National Institutes of Health) | Dr. Hallett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Hallett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine. Dr. Hallett has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Brainsway. Dr. Hallett has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for VoxNeuro. Dr. Hallett has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for QuantalX. Dr. Hallett has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Hallett has received intellectual property interests from a discovery or technology relating to health care. Dr. Hallett has received publishing royalties from a publication relating to health care. Dr. Hallett has received publishing royalties from a publication relating to health care. Dr. Hallett has received publishing royalties from a publication relating to health care. Dr. Hallett has received publishing royalties from a publication relating to health care. Dr. Hallett has received personal compensation in the range of $500-$4,999 for serving as a Speaker with International Parkinson and Movement Disorder Society. Dr. Hallett has a non-compensated relationship as a Past-President with Functional Neurological Disorder Society that is relevant to AAN interests or activities. |
| Tanuja Chitnis, MD, FAAN (Brigham and Women's Hospital) | Dr. Chitnis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Chitnis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche-Genentech. Dr. Chitnis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octave Biosciences. Dr. Chitnis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. The institution of Dr. Chitnis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Chitnis has received research support from Novartis. The institution of Dr. Chitnis has received research support from Sanofi. The institution of Dr. Chitnis has received research support from Octave. The institution of Dr. Chitnis has received research support from Genentech-Roche. The institution of Dr. Chitnis has received research support from Tiziana Life Sciences. The institution of Dr. Chitnis has received research support from Bristol-Myers Squibb. The institution of Dr. Chitnis has received research support from Wesley Clover. |